{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:17:56Z","timestamp":1779124676827,"version":"3.51.4"},"reference-count":18,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2621,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2257.1995.tb00322.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T17:18:41Z","timestamp":1280251121000},"page":"75-80","source":"Crossref","is-referenced-by-count":79,"title":["Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia"],"prefix":"10.1111","volume":"17","author":[{"given":"B.J.","family":"BOUGHTON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"JACKSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"LIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"SMITH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB1|cit1","first-page":"203","volume-title":"Clinical Applications of Intravenous Immunoglobulin","author":"Attard","year":"1992"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB2|cit2","first-page":"236","article-title":"Chronic lymphocytic leukaemia: recommendations for diagnosis staging and response criteria","volume":"110","author":"Binet","year":"1989","journal-title":"International Workshop on CLL Annuls Internal Medicine"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB3|cit3","first-page":"373","volume-title":"Chronic Lymphocytic Leukaemia: Recent Progress, Future Advances","author":"Bunch","year":"1987"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB4|cit4","first-page":"73","volume-title":"The lymphoid leukaemias","author":"Catovsky","year":"1990"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB5|cit5","first-page":"291","article-title":"Mechanisms of infection in chronic, lymphocytic leukaemia","volume":"24","author":"Chapel","year":"1987","journal-title":"Seminars in Hacmatolouy"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(88)90614-9","article-title":"Home intravenous immunoglobulin therapy","volume":"ii","author":"Chapel","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB7|cit7","first-page":"97","volume-title":"Intravenous Immunoglobulin: Prevention and Treatment of Disease","author":"Chapel","year":"1990"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00918268","article-title":"Immunoglobulin replacement in patients with CLL: kinetics of immunoglobulin metabolism","volume":"12","author":"Chapel","year":"1992","journal-title":"Journal of Clinical Immunology"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau phase multiple myeloma","volume":"ii","author":"Chapel","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198810063191403","article-title":"Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukaemia","volume":"319","author":"Cooperative Group for the study of immunoglobulin in chronic lymphocytic leukaemia","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Cross over study of immunoglobulin replacement therapy in patients with low grade B cell tumours","volume":"73","author":"Griffiths","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB12|cit12","first-page":"1","article-title":"Chronic lymphocytic leukaemia: clinical studies based on 189 cases followed for a long time","volume":"18","author":"Hansen","year":"1973","journal-title":"Scandinavian Journal of Haematology (suppl)"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB13|cit13","first-page":"415","volume-title":"Neoplastic Diseases of the Blood","author":"Jacobson","year":"1991"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB14|cit14","first-page":"5","article-title":"Intravenous Immunoglobulins:","volume":"8","author":"NIH Consensus Statement","year":"1990","journal-title":"NIH Development Conference"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB15|cit15","first-page":"97","volume-title":"Neoplastic Diseases of the Blood","author":"Rai","year":"1991"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(87)90494-6","article-title":"High dose versus low dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease","volume":"i","author":"Roifman","year":"1987","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB17|cit17","first-page":"123","volume-title":"Clinical Uses of Immunoglobulins Intravenous","author":"Schedel","year":"1986"},{"key":"10.1111\/j.1365-2257.1995.tb00322.x-BIB18|cit18","first-page":"43","volume-title":"Clinical Applications of Intravenous Immunoglobulin Therapy","author":"Yap","year":"1992"}],"container-title":["Clinical &amp; Laboratory Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2257.1995.tb00322.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2257.1995.tb00322.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T02:35:32Z","timestamp":1625452532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2257.1995.tb00322.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":18,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2257.1995.tb00322.x","relation":{},"ISSN":["0141-9854"],"issn-type":[{"value":"0141-9854","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}